B |
2020-11-10 09:02:20.0 |
Akebia Therapeutics |
AKBA |
WELLINGTON MANAGEMENT GROUP LLP |
12.35% |
view |
B |
2020-02-13 16:27:28.0 |
Akebia Therapeutics |
AKBA |
Nantahala Capital Management |
5.7% |
view |
B |
2019-02-14 16:30:49.0 |
Akebia Therapeutics |
AKBA |
ABRAMS CAPITAL MANAGEMENT |
n/a |
view |
S |
2018-12-21 16:34:17.0 |
Akebia Therapeutics |
AKBA |
Nantahala Capital Management |
4.7% |
view |
B |
2018-12-07 17:22:19.0 |
Akebia Therapeutics |
AKBA |
ABRAMS CAPITAL MANAGEMENT |
n/a |
view |
B |
2018-09-26 16:03:45.0 |
Akebia Therapeutics |
AKBA |
Nantahala Capital Management |
9.8% |
view |
S |
2018-08-31 12:02:10.0 |
Akebia Therapeutics |
AKBA |
EAGLE ASSET MANAGEMENT INC |
0.0% |
view |
S |
2018-02-14 10:48:25.0 |
Akebia Therapeutics |
AKBA |
Nantahala Capital Management |
4.1% |
view |
S |
2018-01-08 11:16:47.0 |
Akebia Therapeutics |
AKBA |
EAGLE ASSET MANAGEMENT INC |
5.75% |
view |
S |
2017-03-06 11:33:19.0 |
Akebia Therapeutics |
AKBA |
EAGLE ASSET MANAGEMENT INC |
7.0% |
view |
S |
2018-02-14 11:28:05.0 |
FireEye |
FEYE |
SHAPIRO CAPITAL MANAGEMENT LLC |
9.26% |
view |
B |
2017-07-10 10:06:19.0 |
FireEye |
FEYE |
SHAPIRO CAPITAL MANAGEMENT LLC |
10.85% |
view |
S |
2016-02-12 17:36:09.0 |
FireEye |
FEYE |
Capital Research Global Investors |
3.3% |
view |
S |
2015-10-13 14:07:18.0 |
FireEye |
FEYE |
Norwest Venture Partners IX |
n/a |
view |
B |
2015-02-13 15:33:02.0 |
FireEye |
FEYE |
Capital Research Global Investors |
6.1% |
view |
B |
2014-02-14 14:14:04.0 |
FireEye |
n/a |
Norwest Venture Partners IX |
7.9% |
view |